These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 18854344)
1. Early onset of hyperuricaemia and gout following treatment for female to male gender reassignment. Pui K; Waddell C; Dalbeth N Rheumatology (Oxford); 2008 Dec; 47(12):1840-1. PubMed ID: 18854344 [No Abstract] [Full Text] [Related]
2. Management of hyperuricemia and gout in CKD. Gaffo AL; Saag KG Am J Kidney Dis; 2008 Nov; 52(5):994-1009. PubMed ID: 18971014 [No Abstract] [Full Text] [Related]
5. [Diet therapy in hyperuricemia and gout: warnings about meat and alcohol]. Müller SD Pflege Z; 2002 Sep; 55(9):635-7. PubMed ID: 12371285 [No Abstract] [Full Text] [Related]
6. Consider gout in patients with risk factors, regardless of age. Olaniyi-Leyimu BY Am Fam Physician; 2008 Jul; 78(2):176. PubMed ID: 18697500 [No Abstract] [Full Text] [Related]
7. [Recent achievements available for the treatment of hyperuricemia and gout. Preface]. Hosoyamada M Nihon Yakurigaku Zasshi; 2010 Dec; 136(6):315. PubMed ID: 21218662 [No Abstract] [Full Text] [Related]
8. Inadequate psychological assessment for female to male gender reassignment. Nancarrow M Australas Psychiatry; 2011 Dec; 19(6):537-8. PubMed ID: 22077308 [No Abstract] [Full Text] [Related]
9. Update on the management of hyperuricemia and gout. Pillinger MH; Keenan RT Bull NYU Hosp Jt Dis; 2008; 66(3):231-9. PubMed ID: 18937638 [TBL] [Abstract][Full Text] [Related]
10. Gout in renal allograft recipients according to the pretransplant hyperuricemic status. Hernández-Molina G; Cachafeiro-Vilar A; Villa AR; Alberú J; Rull-Gabayet M Transplantation; 2008 Dec; 86(11):1543-7. PubMed ID: 19077887 [TBL] [Abstract][Full Text] [Related]
11. [Treatment of transsexuals]. Tiitinen A; Suominen S; Holi M Duodecim; 2003; 119(21):2045-50. PubMed ID: 14655535 [No Abstract] [Full Text] [Related]
12. The genetics of gout and hyperuricaemia. SMYTH CJ; COTTERMAN CW; FREYBERG RH Ann Rheum Dis; 1948 Dec; 7(4):248. PubMed ID: 18207850 [No Abstract] [Full Text] [Related]
13. Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout. Becker MA; Schumacher HR; MacDonald PA; Lloyd E; Lademacher C J Rheumatol; 2009 Jun; 36(6):1273-82. PubMed ID: 19286847 [TBL] [Abstract][Full Text] [Related]
14. [Epidemiology of hyperuricemia]. Tomita M; Murayama T; Mizuno S Nihon Rinsho; 2003 Jan; 61 Suppl 1():178-83. PubMed ID: 12629714 [No Abstract] [Full Text] [Related]
18. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial. Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369 [TBL] [Abstract][Full Text] [Related]
19. [Transsexualism in adolescence. Literature review]. Thimm D; Kreuzer EM Prax Kinderpsychol Kinderpsychiatr; 1984; 33(2):70-5. PubMed ID: 6709601 [No Abstract] [Full Text] [Related]
20. Pyrazinamide induced hyperuricaemia presenting as severe bilateral leg cramps. Gupta S; Gupta V; Kapoor B; Kapoor V J Indian Med Assoc; 2007 Jun; 105(6):341-2. PubMed ID: 18232182 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]